Fig. 4From: Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patientsOverall survival and progression-free survival analysis for the good (a, b) and poor (c, d) short-term response subgroupsBack to article page